Therefore, it may be highly significant to study the mechanism of using caspase molecules to inhibit transformation from chronic hepatitis to HCC in patients with chronic hepatitis C or NASH, like the caspase molecular inhibitors in a report [ 73 , 74 ].
← all excerpts
Senescence and cell death in chronic liver injury: roles and mechanisms underlying hepatocarcinogenesis.
1
—
—